2020
- Earnings per share
- 8.76p
(2019 5.77p) - Net assets per share
- 51p
(2019 41.4p) - Pre-tax profit
- £4,184,000
(2019 £2,350,000) - Revenue
- Fair value of the portfolio
- £19,444,000
(2019 £13,252,000)
2019 / 20
- Earnings per share
- H1 2019 / 2020 – 4.66p
(Dec 2018 3.18p) - Net assets per share
- 46.6p
(June 2019 41.4p) - Pre-tax profit
- £2,088,000
(Dec 2018 1,247,000) - Revenue
- Fair value of the portfolio
- £17,141,000
(June 2019 £13,689,000)
2019
- Earnings per share
- 5.77p
- Net assets per share
- 41.4p
- Pre-tax profit
- £2,350,000
- Revenue
- Fair value of the portfolio
- £13,252,000
- Portfolio companies announce 10 new industry collaboration agreements. Four new companies join Frontier IP portfolio.
- Exscientia raises $26 million Series B funding, signs collaboration agreements with Roche, Celgene and GT Apeiron, meets first milestones for GSK and Sanofi.
2018
- Earnings per share
- 2.36p
- Net assets per share
- 33.2p
- Pre-tax profit
- £902,000
- Revenue
- Fair value of the portfolio
- 9,041,000
- Molendotech signs collaboration agreement with Palintest, part of FTSE 100 group Halma plc; raises £500,000; Palintest launches water-testing kit based on its IP
- Frontier IP increases stake in Fieldwork in return for providing direct, hands-on support for technical development
2017
- Earnings per share
- 3.73p
- Net assets per share
- 30.7p
- Pre-tax profit
- £1,229,000
- Revenue
- Fair value of the portfolio
- 6,729,000
- Exscientia signs major collaboration agreements with Sanofi and GSK; receives €15 million investment from Evotec
- Molendotech and The Vaccine Group spun out from the University of Plymouth to commercialise their water testing and vaccines to tackle zoonotic diseases technologies respectively
2016
- Earnings per share
- 4.08p
- Net assets per share
- 24.9p
- Pre-tax profit
- £1,131,000
- Revenue
- Fair value of the portfolio
- 4,651,000
- Exscientia signs collaboration agreement with Evotec AG
- Innovate UK awards Nandi £1m grant
- Agreement signed with NOVA University Lisbon, NOVA School of Science and Technology (FCT Nova)
- Tarsis Technology spun out of the University of Cambridge
- Fieldwork Robotics incorporated to develop agricultural robots
2015
- Earnings per share
- 2.76p
- Net assets per share
- 20.9p
- Pre-tax profit
- £647,000
- Revenue
- Fair value of the portfolio
- 2,812,000
- Alusid raises £266,000 to fund design of its first product
- Pulsiv Solar raises £500,000 to accelerate product development
2014
- Earnings per share
- 0.13p
- Net assets per share
- 18.1p
- Pre-tax profit
- £27,000
- Revenue
- Fair value of the portfolio
- £1,291,000
- Nandi Proteins raises £660,000 to support development of its technology to replace E-number additives, fat and gluten in food
- Exscientia signs collaboration agreement with Sunovion Pharmaceuticals
- Cambridge Simulation Solutions spun out from the University of Cambridge
